The Cost-Effectiveness of Atypicals in the UK
Reductions in Human Papillomavirus-Disease Resource Use and Costs with Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccination
Cost-Effectiveness of a Low-Calorie Diet and Orlistat for Obese Persons
Economic Valuation of Informal Care
Drotrecogin Alfa's Impact on Intensive Care Workload in Real Life Practice
Statin Cost-Effectiveness Comparisons Using Real-World Effectiveness Data
Expected Value of Perfect Information
Balancing Equity and Efficiency in Health Priorities in Ghana
Cost-Effectiveness of Preventing Hip Fractures by Hip Protectors in Elderly Institutionalized Residents in Germany
Psychometric Equivalence of the OAB-q in Danish, German, Polish, Swedish, and Turkish
Estimation of Life Expectancy and the Expected Years of Life Lost in Patients with Major Cancers
Willingness to Accept versus Willingness to Pay in a Discrete Choice Experiment
Sociodemographic and Clinical Correlates of Utility Scores in Alzheimer's Disease
Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available)
A Predictive Model of Health State Utilities for HIV Patients in the Modern Era of Highly Active Antiretroviral Therapy
Health State Utilities in Latent and Active Tuberculosis
Validity of the EuroQoL (EQ-5D) Instrument in a Greek General Population
Hispanic Valuation of the EQ-5D Health States
Health State Utility Scores for Cancer-Related Anemia through Societal and Patient Valuations
Estimating Quality Weights for EQ-5D Health States with the Time Trade-Off Method in South Korea
Factors Associated with Variation in Utility Scores among Patients with Prostate Cancer
Citizen's Preferences Regarding Principles to Guide Health-Care Allocation Decisions in Thailand
Discrete-Event Simulation Applied to Analysis of Waiting Lists. Evaluation of a Prioritization System for Cataract Surgery
“Price Management” and Its Impact on Hospital Pharmaceutical Expenditure and the Availability of Medicines in New Zealand Hospitals
REVIEWER ACKNOWLEDGMENT